Literature DB >> 11214783

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

M Rønning1, H S Blix, B T Harbø, H Strøm.   

Abstract

OBJECTIVE: To investigate whether published drug utilisation studies contain satisfactory references to the ATC/DDD version applied and thus are usable for comparative purposes. METHODS AND
RESULTS: A literature survey of drug utilisation studies was made. Seventy-three articles were identified by two Medline searches, one in 1996 and another in 1998. The articles were classified into four different groups. Groups 1 and 2 give proper references to the defined daily doses (DDDs) used in the studies, either by full reference to the version of the ATC Index with DDDs or by listing the actual DDDs used. The articles in groups 1 and 2 represent 46% of the articles in the survey. The articles classified in groups 3 and 4 give references only to general articles about the anatomical therapeutic chemical classification (ATC)/DDD system or no references at all. Fifty-four percent of the articles in the survey were classified in these groups. In these articles it is not possible to identify which DDDs have been used in the presentation of drug consumption data.
CONCLUSIONS: According to the results from our literature survey, it is not common practice to include the ATC codes and the DDD values used or to make reference to the versions of the ATC/DDD index used when results from drug utilisation studies are published. One possible reason for this might be little or no knowledge about the ATC/DDD system as a dynamic system in which alterations are made annually. The lack of references to the actual DDDs used in the studies make comparisons between different data sets difficult and misleading.

Mesh:

Substances:

Year:  2000        PMID: 11214783     DOI: 10.1007/s002280000200

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Automated signal generation in prescription-event monitoring.

Authors:  Emma Heeley; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.

Authors:  R H Vander Stichele; M M Elseviers; M Ferech; S Blot; H Goossens
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

3.  Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Authors:  Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  The impact of obesity on drug prescribing in primary care.

Authors: 
Journal:  Br J Gen Pract       Date:  2005-10       Impact factor: 5.386

6.  Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada.

Authors:  James M Hutchinson; David M Patrick; Fawziah Marra; Helen Ng; William R Bowie; Laurie Heule; Mark Muscat; Dominique L Monnet
Journal:  Can J Infect Dis       Date:  2004-01

7.  Problems in collecting comparable national drug use data in Europe: the example of antibacterials.

Authors:  Marit Rønning; Hege Salvesen Blix; Hanne Strøm; Eva Skovlund; Morten Andersen; Robert Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2003-03-18       Impact factor: 2.953

8.  Changes in drug treatment in the elderly between 1971 and 2000.

Authors:  B Lernfelt; O Samuelsson; I Skoog; S Landahl
Journal:  Eur J Clin Pharmacol       Date:  2003-08-16       Impact factor: 2.953

9.  Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patients.

Authors:  Philip Sloane; Jena Ivey; Mary Roth; Mary Roederer; Christianna S Williams
Journal:  Contemp Clin Trials       Date:  2007-06-26       Impact factor: 2.226

10.  Policies to enhance prescribing efficiency in europe: findings and future implications.

Authors:  Brian Godman; William Shrank; Morten Andersen; Christian Berg; Iain Bishop; Thomas Burkhardt; Kristina Garuoliene; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Julie Lonsdale; Rickard E Malmström; Jaana E Martikainen; Vita Samaluk; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; Lesley Tilson; F Cankat Tulunay; Vera Vlahović-Palčevski; Kamila Wendykowska; Bjorn Wettermark; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2011-01-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.